BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6430503)

  • 1. 24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats.
    Goodman WG; Baylink DJ; Sherrard DJ
    Calcif Tissue Int; 1984 Mar; 36(2):206-13. PubMed ID: 6430503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of bone matrix formation, mineralization, and resorption in thyroparathyroidectomized rats.
    Wergedal J; Stauffer M; Baylink D; Rich C
    J Clin Invest; 1973 May; 52(5):1052-8. PubMed ID: 4700483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of rachitic rat bones to 1,25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption.
    Gallagher JA; Beneton M; Harvey L; Lawson DE
    Endocrinology; 1986 Oct; 119(4):1603-9. PubMed ID: 3757903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation, mineralization, and resorption of bone in vitamin D-deficient rats.
    Baylink D; Stauffer M; Wergedal J; Rich C
    J Clin Invest; 1970 Jun; 49(6):1122-34. PubMed ID: 5422016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 1 alpha, 24(R)-dihydroxyvitamin D3 on calcium metabolism in the rat.
    Yamada S; Bonjour JP; Fleisch H
    Acta Endocrinol (Copenh); 1986 Apr; 111(4):572-6. PubMed ID: 3705889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by aminohydroxypropylidene bisphosphonate (AHPrBP) of 1,25(OH)2 vitamin D3-induced stimulated bone turnover in the mouse.
    Marie PJ; Hott M; Garba MT
    Calcif Tissue Int; 1985 May; 37(3):268-75. PubMed ID: 3926276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoinduction by implants of demineralized allogeneic bone matrix is diminished in vitamin D-deficient rats.
    Vandersteenhoven JJ; DeLustro FA; Bell NH; Turner RT
    Calcif Tissue Int; 1988 Jan; 42(1):39-45. PubMed ID: 3129166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration that the vitamin D metabolite 1,25(OH)2-vitamin D3 and not 24R,25(OH)2-vitamin D3 is essential for normal insulin secretion in the perfused rat pancreas.
    Kadowaki S; Norman AW
    Diabetes; 1985 Apr; 34(4):315-20. PubMed ID: 2982684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of vitamin D metabolites (25 OHD3--12,5 (OH)2D3--24.25 (OH)2D3--25.26 (OH)2D3) on vitamin D deficient rats.
    Queille ML; Miravet L; Bordier P; Redel J
    Biomedicine; 1978; 28(4):237-42. PubMed ID: 737274
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of 1 alpha,25- and 24(R),25-dihydroxyvitamin D3 on bone constituents during early mineralization in the rat.
    Vukicević S; Bagi C; Vujicić G; Krempien B; Stavljenić A; Herak M
    Bone Miner; 1986 Oct; 1(5):383-96. PubMed ID: 3509782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of 1 alpha-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on experimentally induced heterotopic ossification in rats.
    Lindholm TC; Lindholm TS; Nilsson OS; Sjökvist G
    Scand J Rheumatol; 1986; 15(1):68-74. PubMed ID: 3485817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting effects of 1,25-dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse.
    Marie PJ; Hott M; Garba MT
    Metabolism; 1985 Aug; 34(8):777-83. PubMed ID: 3839559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of bone volume in vitamin D-repleted rats by massive administration of 24R,25(OH)2D3.
    Nakamura T; Kurokawa T; Orimo H
    Calcif Tissue Int; 1988 Oct; 43(4):235-43. PubMed ID: 3145129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
    Gunness-Hey M; Hock JM; Gera I; Fonseca J; Poser J; Bevan J; Raisz LG
    Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of vitamin D on bone in vivo.
    Tam CS; Heersche JN; Jones G; Murray TM; Rasmussen H
    Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
    Sergeev IN; Blazheevich NV; Kaplanskiĭ AS; Shvets VN; Belakovskiĭ MS
    Vopr Med Khim; 1987; 33(1):100-7. PubMed ID: 3495067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth and remodeling of rat bones during hypokinesia (histomorphometric study)].
    Kabitskaia OE; Savik ZF; Kaplanskiĭ AS; Shvets VN; Sergeev IN
    Kosm Biol Aviakosm Med; 1984; 18(4):49-55. PubMed ID: 6332944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic study of the effect of 1,25-dihydroxyvitamin D3 on bone matrix synthesis in vitamin D replete rats.
    Hock JM; Kream BE; Raisz LG
    Calcif Tissue Int; 1982 Jul; 34(4):347-51. PubMed ID: 6814724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of vitamin D metabolites on the calcification of cartilage matrix and the C-propeptide of type II collagen (chondrocalcin).
    Hinek A; Poole AR
    J Bone Miner Res; 1988 Aug; 3(4):421-9. PubMed ID: 3265578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.